Suitability of tissue tolerable plasmas (TTP) for the management of chronic wounds

Clinical Plasma Medicine

Volumn 1, Issue 1, 2013, Pages 11-18

  Kramer, A ^a   Lademann, J ^b   Bender, C ^a   Sckell, A ^a   Hartmann, B ^c   Munch S ^c   Hinz, P ^a   Ekkernkamp, A ^a,c   Matthes, R ^a   Koban, I ^a   Partecke, I ^d   Heidecke, C D ^d   Masur, K ^e   Reuter, S ^e   Weltmann, K D ^f   Koch, S ^g   Assadian, O ^h  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Trauma Center   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e Centre for Innovation Competence Plasmatis   (Germany)

^f LEIBNIZ INSTITUTE FOR PLASMA SCIENCE AND TECHNOLOGY   (Germany)

^g Institute of Pathology   (Germany)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chronic wound; Cold atmospheric pressure plasmas; Kinpen09; Octenidine; Polihexanide; Tissue Tolerable Plasmas (TTP)

Indexed keywords

OCTENIDINE;

CHRONIC WOUND; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PLASMA; PRIORITY JOURNAL; REVIEW; TISSUE TOLERABLE PLASMA; WOUND HEALING;

EID: 84878380844     PISSN: 22128166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpme.2013.03.002     Document Type: Review

References (82)

1. Kramer A., Hübner N.O., Weltmann K.D., et al. Polypragmasia in the therapy of infected wounds - conclusions drawn from the perspectives of low temperature plasma technology for plasma wound therapy. GMS Krankenhhyg Interdiszip (Germany) 2008, 3(1). pDoc13.
2. Hinz P., Boenigk I., Ekkernkamp A., et al. Prinzipien der chirurgischen Wundbehandlung. Gynäkologische Praxis 2011, 35:711-719.
3. Bruck J.C., Büttemeyer R., Grabosch A., et al. More arguments in favor of myocutaneous flaps for the treatment of pelvic pressure sores. Annals of Plastic Surgery 1991, 26:85-88.
4. Hübner N.O., Assadian O., Müller G., et al. Anforderungen an die Wundreinigung mit Wasser. GMS Krankenhaushyg Interdiszip 2007 2007, 2(2). Doc61 (20071228).
5. Petrisor B., Sun X., Bhandari M., et al. Fluid lavage of open wounds (FLOW): a multicenter, blinded, factorial pilot trial comparing alternative irrigating solutions and pressures in patients with open fractures. Journal of Trauma 2011, 71(3):596-606.
6. Fernandez R., Griffiths R., Ussia C. Water for wound cleansing. Cochrane Database of Systematic Reviews 2002, 2.
7. Daeschlein G., Krüger W.H., Selepko C., et al. Hygienic safety of reusable tap water filters (Germlyser) with an operating time of 4 or 8 weeks in a haematological oncology transplantation unit. BMC Infectious Diseases 2007, 7:45.
8. Dissemond J., Assadian O., Gerber V., et al. Classification of wounds at risk and their antimicrobial treatment with polihexanide: a practice-oriented expert recommendation. Skin Pharmacology and Physiology 2011, 24(5):245-255.
9. Reuter S., Winter J., Schmidt-Bleker A., et al. Controlling the ambient air affected reactive species composition in the effluent of an argon plasma jet. IEEE Transaction of Plasma Science 2012, 40(11):2788-2794.
10. Tipa R.S. Kroesen GMW. Plasma-stimulated wound healing. IEEE Transactions on Plasma Science 2011, 39(11):2978-2979.
11. Weltmann K.D., Kindel E., Brandenburg R., et al. Atmospheric pressure plasma jet for medical therapy: plasma parameters and risk estimation. Contributions to Plasma Physics 2009, 49(9):631-640.
12. Kramer A., Hübner N.O., Assadian O., et al. Chancen und Perspektiven der Plasmamedizin durch Anwendung von gewebekompatiblen Atmosphärendruckplasmen (Tissue Tolerable Plasmas, TTP). GMS Krankenhaushygiene Interdisziplinär 2009, 4(2). Doc10.
13. Hartel M., Hoffmann G., Wente M.N., et al. Randomized clinical trial of the influence of local water-filtered infrared A irradiation on wound healing after abdominal surgery. British Journal of Surgery 2006, 93(8):952-960.
14. Mercer J.B., Nielsen S.P., Hoffmann G. Improvement of wound healing by water-filtered infrared-A (wIRA) in patients with chronic venous stasis ulcers of the lower legs including evaluation using infrared thermography. GMS German Medical Science 2008, 6. (Doc11).
15. Tai G., Reid B., Cao L., Zhao M. Electrotaxis and wound healing: experimental methods to study electric fields as a directional signal for cell migration. Methods in Molecular Biology 2009, 571:77-97.
16. Weltmann K.D., Polak M., Masur K., et al. Plasma processes and plasma sources in medicine. Contributions to Plasma Physics 2012, 52(7):644-654.
17. Fricke K., Reuter S., Schulz von der Gathen V., et al. Investigation of surface etching of poly(ether ether ketone) by atmospheric-pressure plasmas. IEEE Transactions on Plasma Science 2012, 40(11):2900-2911.
18. Foest R., Kindel E., Ohl A., et al. Non-thermal atmospheric pressure discharges for surface modification. Plasma Physics and Controlled Fusion 2005, 47:B525-B536.
19. Weltmann K.D., Brandenburg R., von Woedtke T., et al. Antimicrobial treatment of heat sensitive products by miniaturized atmospheric pressure plasma jets (APPJs). Journal of Physics D: Applied Physics 2008, 41(19):194008.
20. Lademann J., Richter H., Alborova A., et al. Risk assessment of the application of a plasma-jet in dermatology. Journal of Biomedical Optics 2009, 14(5):054025.
21. Lademann O., Richter H., Patzelt A., et al. Application of a plasma-jet for skin antisepsis: analysis of the thermal action of the plasma by laser scanning microscopy. Laser Physics Letters 2010, 7(6):458-462.
22. Fluhr J.W., Sassning S., Lademann O., et al. In vivo skin treatment with tissue tolerable plasma influences skin physiology and antioxidant profile in human stratum corneum. Experimental Dermatology 2012, 21(2):130-134.
23. Partecke L.I., Evert K., Haugk J., et al. Tissue Tolerable Plasma (TTP) induce apoptosis in the human pancreatic cancer cell line Colo-357 in vitro and in vivo. BMC Cancer 2012, 12:473. 10.1186/1471-2407-12-473.
24. Bussiahn R., Kindel E., Lange H., et al. Spatially and temporally resolved measurements of argon metastable atoms in the effluent of a cold atmospheric pressure plasma jet. Journal of Physics D: Applied Physics 2010, 43(16):1-6.
25. Reuter S., Tresp H., Wende K., et al. From RONS to ROS: tailoring plasma jet treatment of skin cells. IEEE Transactions on Plasma Science 2012, 40(11):2986-2993.
26. Bender C, Pavlovic D, Wegner A., et al. Intravital Fluorescence Microscopy for the Assessment of Microcirculation and Leukocyte-Endothelium Interaction after application of Tissue Tolerable Plasma in the HET-CAM. In: Mikikian M., Rabat H., Robert E., et al. (eds) Abstracts 4th Int Conf Plasma Medicine, Orleans, 2012. http://icpm4.sciencesconf.org/browse/speaker?authorid=183254.
27. Kramer A. Hand disinfection and antiseptic of skin, mucous membranes, and wounds. Dermatopharmacology of Topical Preparations 2000, 121-134. Springer, Berlin. B. Gabard, P. Elsner, C. Surber, P. Treffel (Eds.).
28. Pitten F.A., Werner H.P., Kramer A.A. standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. Journal of Hospital Infection 2003, 55:108-115.
29. Pompl R., Jamitzky F., Shimizu T., et al. The effect of low-temperature plasma on bacteria as observed by repeated AFM imaging. New Journal of Physics 2009, 11:115023.
30. Laroussi M., Tendero C., Lu X., et al. Inactivation of bacteria by the plasma pencil. Plasma Processes and Polymers 2006, 3(6-7):470-473.
31. Shimizu T., Steffes B., Pompl R., et al. Characterization of microwave plasma torch for decontamination. Plasma Processes and Polymers 2008, 5(6):577-582.
32. Morfill G.E., Shimizu T., Steffes B., et al. Nosocomial infections-a new approach towards preventive medicine using plasmas. New Journal of Physics 2009, 11:115019.
33. Matthes R., Hübner N.O., Bender C., et al. Screeningmethode zur Qualitätsprüfung flächiger Plasmaquellen mit dem Mikroorganismen-Agar-Test (MAT). GMS Krankenhaushygiene Interdisziplinär 2010, 5(2). Doc02 (20100921).
34. Ehlbeck J., Brandenburg R., von Woedtke T., et al. PLASMOSE-antimicrobial effects of modular atmospheric plasma sources. GMS Krankenhaushygiene Interdisziplinär 2008, 3(1). (Doc14).
35. Ermolaeva S.A., Varfolomeev A.F., Chernukha M.Y., et al. Bactericidal effects of non-thermal argon plasma in vitro, in biofilms and in the animal model of infected wounds. Journal of Medical Microbiology 2011, 60(Pt 1):75-83.
36. Koban I., Hübner N.O., Matthes R., et al. Antiseptische Wirksamkeit ausgewählter Wirkstoffe und von tissue tolerable plasma (TTP) auf C. albicans-Biofilme-hat der Reifegrad des Biofilms einen Einfluss?. GMS Krankenhaushygiene Interdisziplinär 2009, 4(2). Doc09 (20091216).
37. Koban I., Matthes R., Hübner N.O., et al. Treatment of Candida albicans biofilms with low temperature plasma induced by dielectric barrier discharge and atmospheric pressure plasma jet. New Journal of Physics 2010, 12:073039.
38. Hübner N.O., Matthes R., Koban I., et al. Efficacy of chlorhexidine, polihexanide and tissue-tolerable plasma against pseudomonas aeruginosa biofilms grown on polystyrene and silicone materials. Skin Pharmacology and Physiology 2010, 23(suppl 1):28-34.
39. Koban I., Holtfreter B., Hübner N.O., et al. Antimicrobial efficacy of non-thermal plasma in comparison to chlorhexidine against dental biofilms on titanium discs in vitro-proof of principle experiment. Journal of Clinical Periodontology 2011, 38(10):956-965.
40. Koban I., Hübner N.O., Kramer A., et al. XTT assay of ex vivo saliva biofilms to test antimicrobial influences. GMS Krankenhaushygiene Interdisziplinär 2012, 7(1). (Doc06).
41. Matthes R., Bender C., Hübner N.O., et al. Influencing of the penetration of Pseudomonas aeruginosa into a 3-D epidermis model and the inactivation with tissue tolerable plasma. GMS Krankenhaushygiene Interdisziplinär 2009, 4(2). Doc08 (20091216).
42. Hammann A., Hübner N.O., Bender C., et al. Antiseptic efficacy and tolerance of tissue tolerable plasma (TTP) compared with two wound antiseptics on artificial bacterially contaminated eyes from commercially slaughtered pigs. Skin Pharmacology and Physiology 2010, 23:328-332.
43. http://www.oecd-ilibrary.org/environment/test-no-437-bovine-corneal-opacity-and-permeability-test-method-for-identifying-ocular-corrosives-and-severe-irritants_9789264076303-en.
44. http://www.oecd-ilibrary.org/environment/test-no-438-isolated-chicken-eye-test-method-for-identifying-ocular-corrosives-and-severe-irritants_9789264076310-en.
45. Lademann O., Kramer A., Richter H., et al. Skin disinfection by plasma-tissue interaction: comparison of the effectivity of tissue-tolerable plasma and a standard antiseptic. Skin Pharmacology and Physiology 2011, 24(5):284-288.
46. Lademann O., Kramer A., Richter H., et al. Antisepsis of the follicular reservoir by treatment with tissue-tolerable plasma (TTP). Laser Physics Letters 2011, 8(4):1-5.
47. Lange-Asschenfeldt B., Marenbach D., Lang C., et al. Distribution of bacteria in the epidermal layers and hair follicles of the human skin. Skin Pharmacology and Physiology 2011, 24(6):305-311.
48. Matthes R., Koban I., Bender C., et al. Antimicrobial efficacy of an atmospheric pressure plasma jet against biofilms of Pseudomonas aeruginosa and Staphylococcus epidermidis. Plasma Processes Polymers 2013, 10(2):161-166.
49. ®) and selected antiseptics. Dermatology 2006, 212(Suppl. 1):91-93.
50. Geerling G., Baatz J., Harder D., et al. Requirements concerning antiseptics for periorbital, orbital and intraorbital application. Local tolerance. Developments in Ophthalmology 2002, 33:32-56.
51. Abbott A. Cell culture: biology's new dimension. Nature 2003, 424:870-872.
52. Bender C., Matthes R., Kindel E., et al. The irritation potential of nonthermal atmospheric pressure plasma in the HET-CAM. Plasma Processes and Polymers 2010, 7(3-4):318-326.
53. Bender C., Partecke L.I., Kindel E., et al. The modified HET-CAM as an alternative model for the assessment of the inflammatory response to non-thermal gas plasma. Toxicology In Vitro 2011, 25(2):530-537.
54. Kramer A., Roth B., Müller G., et al. Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. a double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacology Physiology 2004, 17:141-146.
55. Bender C., Hübner N.O., Weltmann K.D., et al. Tissue tolerable plasma and polihexanide: are synergistic effects possible to promote healing of chronic wounds? In vivo and in vitro results. Plasma for Bio-Decontamination, Medicine and Food Security. NATO Science for Peace and Security Series-A: Chemistry and Biology 2012, 312-334. Springer, Dordrecht, Netherlands. Z. Machala, K. Hendsel, Y. Akishev (Eds.).
56. Rajnicek A.M., Foubister L.E., McCaig C.D. Growth cone steering by a physiological electric field requires dynamic microtubules, microfilaments and Rac-mediated filopodial asymmetry. Journal of Cell Science 2006, 119(Pt 9):1736-1745.
57. Sen C.K. Wound healing essentials: let there be oxygen. Wound Repair and Regeneration 2009, 17(1):1-18.
58. Müller G., Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. Journal of Antimicrobial Chemotherapy 2008, 61(6):1281-1287.
59. Roth B., Baltzer K. Preliminary treatment of the recipient site and healing of open spongiosa transplant in post-traumatic osteitis. Helvetica Chirurgica Acta 1989, 56:571-572.
60. Roth C., Beule A.G., Kramer A., et al. Response analysis of stimulating efficacy of polihexanide in an in vitro wound model with respiratory ciliary epithelial cells. Skin Pharmacology 2010, 23(Suppl):35-40.
61. Eisenbei W., Siemers F., Amtsberg G., et al. Prospective, double-blinded, randomised controlled trial on the effect of an Octenidine-based hydrogel on bacterial colonisation and epithelialisation of skin graft wounds in burn patients. International Journal of Burns and Trauma 2012, 2(2):71-79.
62. Kramer A., Hübner N.O., Assadian O., et al. Polihexanide-perspectives on clinical wound antisepsis. Skin Pharmacology and Physiology 2010, 23(suppl 1):1-3.
63. Hübner N.O., Kramer A. Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic. Skin Pharmacology and Physiology 2010, 23(suppl 1):17-27.
64. Hübner N.O., Siebert J., Kramer A. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacology and Physiology 2010, 23:244-258.
65. Koburger T., Hübner N.O., Braun M., et al. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. Journal of Antimicrobial Chemotherapy 2010, 65(8):1712-1719.
66. Kaehn K., Eberlein T. In-vitro test for comparing the efficacy of wound rinsing solutions. British Journal of Nursing 2009, 18(4):6-8.
67. Kaehn K. An in-vitro model for comparing the efficiency of wound rinsing solutions. Journal of Wound Care 2009, 18(229-30):232-234.
68. Hübner N.O., Matthes R., Koban I., et al. Efficacy of chlorhexidine, polihexanide and tissue-tolerable plasma against pseudomonas aeruginosa biofilms grown on polystyrene and silicone materials. Skin Pharmacology and Physiology 2010, 23(suppl 1):28-34.
69. Harbs N, Siebert J. In vitro efficacy of octenidine and polihexanide against biofilms composed of Pseudomonas aeruginosa. GMS Krankenhaushyg Interdiszpl 2(2): Doc.45 (20071228).
70. Bartoszewicz M., Rygiel A., Krzeminski M., et al. Penetration of a selected antibiotic and antiseptic into a biofilm formed on orthopedic steel implants. Orthopaedics, Traumatology and Rehabilitation 2007, 9:310-318.
71. Shapiro S., Giertsen E., Guggenheim B. An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses. Caries Research 2002, 36:93-100.
72. Amalaradjou M.A., Norris C.E., Venkitanarayanan K. Effect of octenidine hydrochloride on planktonic cells and biofilms of Listeria monocytogenes. Applied and Environmental Microbiology 2009, 75:4089-4092.
73. Müller G., Kramer A. In vitro action of combinations of selected antimicrobial agents and adult bovine articular cartilage (sesamoid bone). Chemico-Biological Interactions 2003, 145:331-336.
74. ® bei der Peritoneallavage am Modell der experimentell induzierten Peritonitis beim Meerschweinchen. Hygiene and Medizin 2008, 33(5):189-193.
75. Wehner F., Wehner H.D., Schulz M.M. Tödliche intravenöse Infusion eines polyhexanidhaltigen Wundantiseptikums. Archiv für Kriminologie 2009, 223(3-4):108-116.
76. Hogele A.M., Neu J. Wundverschluss nach Wundspülung mit Octenisept ohne Abflussmöglichkeit. Unfallchirurg 2011, 114(1):70-72.
77. Hülsemann W., Habenicht R. Schwere Nebenwirkungen nach Octenisept-Spülung von Perforationswunden im Kindesalter. Handchirurgie Mikrochirurgie Plastische Chirurgie 2009, 41(5):277-282.
78. Franz T., Vogelin E. Aseptic tissue necrosis and chronic inflammation after irrigation of penetrating hand wounds using Octenisept. Journal of Hand Surgery: European Volume 2012, 37(1):61-64.
79. Bender C., Kramer A. Wundheilungsförderung durch kombinierte Anwendung von Tissue Tolerable Plasma und Antiseptika: Fallbeispiele aus der Veterinärmedizin. Hygiene Medizin 2012, 37:27-28.
80. Isbary G., Heinlin J., Shimizu T., et al. Successful and safe use of 2min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. British Journal of Dermatology 2012, S1365-S2133.
81. Ulrich C, Kluschke F, Patzelt A., et al. Effects of tissue-tolerable plasma on chronic wound treatment compared to a modern conventional liquid antiseptic. to British Journal of Dermatology, submitted.
82. 2-laser skin lesions by plasma stimulation. American Journal of Cosmetic Surgery 2012, 29(1):52-56.